D.R. Horton, Inc. (BMV:DHI)

Verve Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 22, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	847,865	1,217,266	633,105	470,124	616,482	607,260
Market Cap Growth	-11.91%	92.27%	34.67%	-23.74%	1.52%	57.83%
Enterprise Value	953,007	1,287,184	693,496	569,031	676,992	659,641
Last Close Price	2780.00	3722.93	1837.67	1523.81	1699.44	1591.55
PE Ratio	11.34	13.07	7.66	4.00	7.20	11.59
PS Ratio	1.30	1.69	1.02	0.70	1.08	1.35
PB Ratio	1.83	2.41	1.57	1.18	1.98	2.27
P/TBV Ratio	1.88	2.47	1.61	1.22	2.04	2.36
P/FCF Ratio	16.14	30.70	8.75	56.58	112.65	24.24
P/OCF Ratio	15.45	28.39	8.45	41.66	56.28	19.35
EV/Sales Ratio	1.46	1.79	1.12	0.85	1.19	1.47
EV/EBITDA Ratio	9.56	10.60	6.27	3.65	6.05	9.86
EV/EBIT Ratio	9.82	10.75	6.36	3.69	6.14	10.17
EV/FCF Ratio	18.14	32.47	9.58	68.49	123.71	26.33
Debt / Equity Ratio	0.30	0.23	0.22	0.32	0.36	0.36
Debt / EBITDA Ratio	1.40	0.97	0.81	0.81	0.99	1.42
Debt / FCF Ratio	2.64	2.98	1.25	15.26	20.42	3.82
Asset Turnover	0.97	1.07	1.13	1.23	1.29	1.18
Inventory Turnover	0.99	1.15	1.18	1.20	1.38	1.31
Quick Ratio	0.56	0.95	0.89	0.46	0.82	0.98
Current Ratio	6.53	6.75	6.57	4.52	5.37	5.31
Return on Equity (ROE)	16.10%	19.63%	22.34%	33.69%	30.66%	21.24%
Return on Assets (ROA)	8.96%	11.13%	12.43%	17.67%	15.66%	10.64%
Return on Capital (ROIC)	10.20%	12.70%	14.37%	20.54%	18.10%	12.18%
Return on Capital Employed (ROCE)	16.60%	19.80%	22.50%	32.20%	27.30%	18.90%
Earnings Yield	8.82%	7.65%	13.05%	25.03%	13.88%	8.63%
FCF Yield	6.19%	3.26%	11.43%	1.77%	0.89%	4.13%
Dividend Yield	1.07%	0.63%	0.95%	1.19%	0.97%	0.97%
Payout Ratio	11.96%	8.31%	7.19%	5.40%	6.93%	10.79%
Buyback Yield / Dilution	5.11%	3.41%	3.24%	3.01%	1.19%	1.91%
Total Shareholder Return	6.18%	4.04%	4.19%	4.19%	2.15%	2.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.